SUBSCRIBE
SUBSCRIBE

Food and Drug Administration (FDA)

NEWS
Business
President Trump: Keep Your Peter (Thiel) Out Of Our FDA Politics
March 1, 2017
 · 
1 min read
What You Missed: Nippon Fine Chemical Formed Human Barricade to Stop FDA Employee
BioMidwest
Pfizer’s Kansas Plant is ‘Out of Control’ and Puts Patients at Risk, Says the FDA
March 1, 2017
 · 
2 min read
And It Begins...President Trump Looks to Cut $1.2 Billion of NIH R&D Spending This Year
Business
Trump Takes Another Shot at the FDA’s ‘Slow And Burdensome’ Approval Process
March 1, 2017
 · 
2 min read
3 Biotechs That Could be Taken Out This Quarter
Policy
6 Biotechs Facing Key FDA Decisions in March
February 27, 2017
 · 
2 min read
Business
This Bay Area Anti-Aging Drug Company Is Secretly Preparing For Trump’s New FDA
February 24, 2017
 · 
1 min read
FDA Approval of Siliq for Psoriasis – How Will the Drug Perform in an Already Overcrowded Market?
Genetown
FDA Approval of Siliq for Psoriasis—How Will the Drug Perform in an Already Overcrowded Market?
February 22, 2017
 · 
2 min read
Policy
A Call For The FDA To Raise The Bar For Clinical Trials Is Flawed
February 22, 2017
 · 
1 min read
What You Missed: Nippon Fine Chemical Formed Human Barricade to Stop FDA Employee
Business
What This Contender for FDA’s Top Job Could Do His First 6 Months on the Gig
February 21, 2017
 · 
3 min read
Policy
With All Due Respect President Trump, Drug Companies Don’t Want a Deregulated FDA
February 16, 2017
 · 
1 min read
Load More
JOBS
IN THE PRESS
Press Releases
PharmaEssentia Announces FDA Approval and U.S. Launch of BESREMi Pen™ (ropeginterferon alfa-2b-njft) for Polycythemia Vera
June 26, 2026
 · 
5 min read
Press Releases
Replimune Announces FDA Acceptance of RP1 Biologics License Application Resubmission for Advanced Melanoma
June 26, 2026
 · 
4 min read
Press Releases
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), each with Trodelvy® (sacituzumab govitecan-hziy) as First-Line Treatment of PD-L1+ (CPS ≥10) Advanced Triple-Negative Breast Cancer (TNBC)
June 25, 2026
 · 
19 min read
Press Releases
U.S. FDA Approves Trodelvy® for First-Line Treatment of Metastatic Triple-Negative Breast Cancer
June 25, 2026
 · 
19 min read
Press Releases
TRYNGOLZA® (olezarsen) approved by the FDA as the first and only treatment to reduce triglycerides and the risk of acute pancreatitis in patients with severe hypertriglyceridemia (sHTG)
June 25, 2026
 · 
10 min read
Press Releases
FDA Approves Pfizer’s IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance
June 25, 2026
 · 
17 min read
Press Releases
ADC Therapeutics Announces Strategic Reorganization to Support ZYNLONTA® Growth Opportunities and Regulatory Priorities
June 24, 2026
 · 
8 min read
Press Releases
Cognition Therapeutics Aligns on Key Aspects of Pivotal Study for Zervimesine (CT1812) in DLB Psychosis Following Receipt of FDA Meeting Minutes
June 24, 2026
 · 
8 min read
Press Releases
UniXell Biotechnology Secures FDA IND Clearance for UX-DA003, Achieving China-U.S. Dual Breakthrough in iPSC Parkinson’s Therapy
June 24, 2026
 · 
4 min read
Press Releases
Life Spine Receives FDA 510(k) Clearance for VersaLift™ Expandable Interbody System Featuring a 6mm Starting Height
June 24, 2026
 · 
1 min read
Load More